Skip to main content

The Natural History of Metastases to the Liver

  • Chapter
Liver Metastases
  • 88 Accesses

Abstract

The liver is the repository of metastatic deposits from virtually any primary tumour site and type. Although most discussions of hepatic metastases focus on those of colorectal origin because of their higher incidence of liver metastases, primaries including sarcomas, breast, kidney and neuroendocrine tumours also metastasize to the liver. According to Tumour, Node, Metastisis classification, tumour deposits in the liver by definition denote distant disease. Thus, the presence of hepatic metastases always indicates a worsening of prognosis, and a significant decrease in the likelihood of cure.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Parker SL, Tong T, Bolden S, Wingo PA. Cancer statistics,1996. CA Cancer J Clin 1996; 46:5–27.

    Article  CAS  Google Scholar 

  2. Levitan N, Hughes KS. Management of non-resectable liver metastases from colorectal cancer. Oncology 1990; 4:77–84.

    PubMed  CAS  Google Scholar 

  3. Kune GA, Kune S, Field B et al. Survival in patients with large bowel cancer. A population-based investigation from the Melbourne Colorectal Cancer Study. Dis Colon Rectum1990; 33:938–946.

    Google Scholar 

  4. Turnbull RB, Jr., Kyle K, Watson FR, Spratt J. Cancer of the colon: The influence of the no touch isolation technique on survival rates. Ann Surg 1967; 166:420–427.

    Article  PubMed  Google Scholar 

  5. Finlay IG, McArdle CS. Occult hepatic metastases in colorectal carcinoma. BrJ Surg 1986; 73:732–735.

    Article  PubMed  CAS  Google Scholar 

  6. Machi J, Isomoto H, Kurohiji Tet al. Accuracy of intraoperative ultrasonography in diagnosing liver metastases from colorectal cancer: Evaluation with postoperative follow-up results. World J Surg 1991; 15:551–557.

    Article  PubMed  CAS  Google Scholar 

  7. Olsen AK. Intraoperative ultrasonography and the detection of liver metastases at laparotomy. Aust NZ J Surg 1980; 50:524–526.

    Article  Google Scholar 

  8. Stadler J, Holscher AH, Adolf J. Intraoperative ultrasonographic detection of occult liver metastases in colorectal cancer. Surg Endosc 1991; 5:36–40.

    Article  PubMed  CAS  Google Scholar 

  9. Goligher JC. The operability of carcinoma of the rectum. BMJ 1941; 393–397.

    Google Scholar 

  10. Hogg L, Pack GK. Diagnostic accuracy of hepatic metastases at laparotomy. Arch Surg 1956; 72:251–252.

    Google Scholar 

  11. Gray BN. Surgeon accuracy in the diagnosis of liver metastases at laparotomy. Aust NZ J Surg 1980; 50:524–526.

    Article  CAS  Google Scholar 

  12. Faivre J, Rat P, Arveux P. Epidemiology of liver metastases from colorectal cancer. In: Nordlinger B, Jaeck D (eds)Treatment of Hepatic Metastases of Colorectal Cancer 1992:33–8. Paris: Springer Verlag.

    Google Scholar 

  13. Gompertz B. On the nature of the function expressive of the law of human mortality and on the new mode of determining the value oflife contingencies. Phil Trans R Soc London 1825 115:5l3–585

    Google Scholar 

  14. Norton L, Simon R. Growth curve of an experimental solid tumor following radiotherapy. JNatl Cancer Inst 1977; 58:1735–1741.

    CAS  Google Scholar 

  15. Finlay IG, Meek D, Brunton F, McArdle CS. Growth rates of hepatic metastases in colorectal carcinoma. Br J Surg 1988; 75:641–644.

    Article  PubMed  CAS  Google Scholar 

  16. Baserga R. The cell cycle. NE JM 1981; 304:453–459.

    Article  PubMed  CAS  Google Scholar 

  17. Retsky MW, Swartzendruber DE, Bame PD, Wardwell RH. Computer model challenges breast cancer treatment strategy. Cancer Invest 1994; 12:559–567.

    Article  PubMed  CAS  Google Scholar 

  18. Radinsky R, Ellis LM. Molecular determinants in the biology ofliver metastases. Surg Oncol Clin NA 1996; 5:215–230.

    CAS  Google Scholar 

  19. Loizidou MC, Lawrence RJ, Holt Set al. Facilitation by partial hepatectomy of tumor growth within the rat liver following the intraportal injection of syngeneic tumor cells. Clin Exp Metastasis 1991; 9:335–349.

    Article  PubMed  CAS  Google Scholar 

  20. Michalopoulos GK. Liver regeneration: Molecular mechanisms of growth control. FASEB J 1990; 4:176–187.

    PubMed  CAS  Google Scholar 

  21. Levy A, Cioce V, Sobel MEet al. Increased expression of the 72 kDa type IV collagenase in human colonic adenocarcinoma. Cancer Res 1991; 51:439–444.

    PubMed  CAS  Google Scholar 

  22. Coulombe J, Pelletier G. Gangliosides and organ-specific metastatic colonization. Int J Cancer 1993; 53:104–109.

    Article  PubMed  CAS  Google Scholar 

  23. Fujita S, Suzuki J, Kinoshita Met al. Inhibition of cell attachment, invasion and metastasis of human carcinoma cells by anti-integrin beta-l subunit antibody. Jpn J Cancer Res 1992; 83:1317–1326.

    CAS  Google Scholar 

  24. Tanabe KK, Ellis LM, Saya H. Expression of the CD44Rl adhesion molecule is increased in human colon adenocarcinomas and metastases. Lancet 1993; 341:725–726.

    Article  PubMed  CAS  Google Scholar 

  25. Ellis LM, Liu W. Vascular endothelial growth factor (VEGF) expression and alternate splicing in non-metastatic and metastatic human colon cancer cell lines. Proc AACR1995; 36:A525.

    Google Scholar 

  26. Taylor I, Mullee MA, Campbell MJ. Prognostic index for the development of liver metastases in patients with colorectal cancer. Br J Surg 1990; 77:499–501.

    Article  PubMed  CAS  Google Scholar 

  27. Morris MJ, Newland RC, Pheils MT, Macpherson JG. Hepatic metastases from colorectal carcinoma: an analysis of survival rates and histopathology. Aust NZJ Surg 1977; 47:365–368.

    CAS  Google Scholar 

  28. Tsuchiya A, Ando Y, Kikuchi Y, Kanazawa Met al. Venous invasion as a prognostic factor in colorectal cancer. Surg Today 1995; 25:950–953.

    Article  PubMed  CAS  Google Scholar 

  29. Pickren JW, Tsukada Y, Lane WW. Liver metastasis: Analysis of autopsy data. In: Weiss L, Gilbert HA, (eds)Liver Metastasis 1982; 222–28. Boston: Hall Medical

    Google Scholar 

  30. Uetsuji S, Yamamura M, Yamamichi Ket al. Absence of colorectal cancer metastases to the cirrhotic liver. Am J Surg 1992; 164:176–177.

    Article  PubMed  CAS  Google Scholar 

  31. Stearns MW, Brinkley GJ. Palliative surgery for cancer of the rectum and colon. Cancer 1954; 7:1016–1019.

    Article  PubMed  Google Scholar 

  32. Bacon HE, Martin PV. The rationale of palliative resection for primary cancer of the colon complicated by liver and lung metastases. Dis Colon Rectum 1964; 7:211–217.

    Article  PubMed  CAS  Google Scholar 

  33. Pestana C, Reitemeyer RJ, Moertel CGet al. The natural history of carcinoma of the colon and rectum. Am J Surg 1964; 108:826–829.

    Article  PubMed  CAS  Google Scholar 

  34. Jaffe BM, Donegan WL, Watson Fet al. Factors influencing survival in patients with untreated hepatic metastases. Surg Gynecol Obstet 1968; 127:1–11.

    PubMed  CAS  Google Scholar 

  35. Bengmark S, Hafstrom 1. The natural history of primary and secondary malignant tumors of the liver: 1. The prognosis for patients with hepatic metastases from colonic and rectal carcinoma at laparotomy. Cancer 1969; 23:198–202.

    Article  PubMed  CAS  Google Scholar 

  36. Oxley EM, Ellis H. Prognosis of carcinoma of the large bowel in the presence of liver metastases. Br J Surg1969; 56:149–152.

    Article  PubMed  CAS  Google Scholar 

  37. Cady B, Monson DO, Swinton NW. Survival of patients after colonic resection for carcinoma with simultaneous liver metastases. Surg Gynecol Obstet 1970; 131:697–700.

    PubMed  CAS  Google Scholar 

  38. Abrams MS, Lerner HJ. Survival of patients at Pennsylvania Hospital with hepatic metastases from carcinoma of the colon and rectum. Dis Colon Rectum 1971; 14:431–434.

    Article  PubMed  CAS  Google Scholar 

  39. Nielson I, Barlslev I, Jensen HE. Carcinoma of the colon with liver metastases. Acta Chir Scand 1971; 137:463–465.

    Google Scholar 

  40. Baden H, Anderson B. Survival of patients with untreated liver metastases from colorectal cancer. Scand J Gastroenterol 1975; 10:221–223.

    PubMed  CAS  Google Scholar 

  41. Wilson SM, Adson MA. Surgical treatment of hepatic metastases from colorectal cancers. Arch Surg 1976; 111:330–334.

    PubMed  CAS  Google Scholar 

  42. Wood CB, Gillis CR, Blumgart LH. A retrospective study of the natural history of patients with liver metastases from colorectal cancer. Clin Onco11976; 2:285–288.

    Google Scholar 

  43. Wanebo HI, Semoglon C, Attiyeh Fet al. Surgical management of patients with primary operable colorectal cancer and synchronous liver metastases. Am J Surg 1978; 135:81–84.

    Article  PubMed  CAS  Google Scholar 

  44. Bengston G, Carlsson G, Hafstrom Let al. Natural history of patients with untreated liver metastases from colorectal cancer. Am J Surg 1981; 141:586–589.

    Article  Google Scholar 

  45. Goslin R, Steele G, Zamcheck Net al. Factors influencing survival in patients with hepatic metastases from adenocarcinoma of the colon and rectum. Dis Colon Rectum 1982; 25:749–754.

    Article  PubMed  CAS  Google Scholar 

  46. Lahr CJ, Soong S-I, Cloud Get al. A multifactorial analysis of prognostic factors in patients with liver metastases from colorectal carcinoma. J Clin Oneal 1983; 1:720–726.

    CAS  Google Scholar 

  47. Wagner JS, Adson MA, van Heerden JAet al. The natural history of hepatic metastases from colorectal cancer: A comparison with resective treatment. Ann Surg 1984; 199:502–508.

    Article  PubMed  CAS  Google Scholar 

  48. Finan PI, Marshall RI, Cooper EHet al. Factors affecting survival in patients presenting with synchronous hepatic metastases from colorectal cancer: A clinical and computer analysis. Br J Surg 1985; 72:373–377.

    Article  PubMed  CAS  Google Scholar 

  49. DeBrauw LM, DeVelde CJH, Bouwhuis-Hoogerwerf M1. Diagnostic evaluation and survival analysis of colorectal cancer patients with liver metastases. J Surg Oneal 1989; 7: 1407–1418.

    Google Scholar 

  50. Palmer M, Petrelli NI, Herrera 1. No treatment option for liver metastases from colorectal adenocarcinoma. Dis Colon Rectum 1989; 32:698–701.

    Article  PubMed  CAS  Google Scholar 

  51. Scheele J, Stangl R, Altendorf-Hofmann A. Hepatic metastases from colorectal carcinoma: Impact of surgical resection on the natural history. Br J Surg 1990; 77:1241–1246.

    Article  PubMed  CAS  Google Scholar 

  52. Stangl R, Altendorf-Hofmann A, Charnley RM, Scheele J. Factors influencing the natural history of colorectal liver metastases. Lancet 1994; 343:1405–1410.

    Article  PubMed  CAS  Google Scholar 

  53. Rougier P, Milan C, Lazorthes F,et al. Prospective study of prognostic factors in patients with unresected hepatic metastases from colorectal cancer. Br J Surg 1995; 82:1397–1400.

    Article  PubMed  CAS  Google Scholar 

  54. Hughes KS, Rosenstein RB, Songhorabodi Set al. Resection of the liver for colorectal carcinoma metastases. Dis Colon Rectum 1988; 31:1–4.

    Article  PubMed  CAS  Google Scholar 

  55. Kemeny MM, Hogan IN, Ganteaune L, Goldberg DA, Terz JJ. Preoperative staging with computerized axial tomography and biochemical tests in patients with hepatic metastases. Ann Surg 1986; 203:169–172.

    Article  PubMed  CAS  Google Scholar 

  56. Ferrucci JT. Liver tumor imaging—current concepts. Radial Clin NA 1994; 32:39–54.

    CAS  Google Scholar 

  57. Soyer P, Bluenke DA, Hruban RHet al. Hepatic metastases from colorectal cancer: Detection and false positive findings with helical CT during arterial portography. Radiology1994; 193:71–74.

    PubMed  CAS  Google Scholar 

  58. Thoeni RF. Clinical applications of magnetic resonance imaging of the liver. Invest Radial 1990; 26:266–273.

    Article  Google Scholar 

  59. Burak WE Jr., Schneebaum S, Kim JAet al. Pilot study evaluating the intraoperative localization of radiolabeled monoclonal antibody CC83 in patients with metastatic colorectal carcinoma. Surgery 1995; 118:103–108.

    Article  PubMed  Google Scholar 

  60. Bertsch DI, Burak WE Jr., Young DCet al. Radioimmunoguided surgery system improves survival for patients with recurrent colorectal cancer. Surgery 1995; 118:634–639.

    Article  PubMed  CAS  Google Scholar 

  61. Kemeny N, Brown DW. Prognostic factors in advanced colorectal carcinoma: the importance of lactic dehydrogenase, performance status and white blood cell count. Am J Med 1983; 74:786–794.

    Article  PubMed  CAS  Google Scholar 

  62. Bedikian AY, Chen TT, Malaky MAet al. Prognostic factors influencing survival of patients with advanced colorectal cancer: Hepatic artery infusion versus systemic intravenous chemotherapy for liver metastases. J Clin Oncol 1984; 2:174–180.

    PubMed  CAS  Google Scholar 

  63. Ekberg J, Tranberg KG, Lunstedt Cet al. Determinant of survival after intra-arterial infusion of 5-fluorouracil for liver metastases from colorectal cancer. A multivariate analysis. J Surg Onco11986; 31:246–254.

    Google Scholar 

  64. Chang AE, Steinberg SM, Culnane Met al. Determinants of survival in patients with unresectable colorectalliver metastases. J Surg Onco 11989; 40:245–251.

    Google Scholar 

  65. Kemeny N, Niedwiecki D, Shurgot Bet al. Prognostic variables in patients with hepatic metastases from colorectal cancer: Importance of medical assessment of liver involvement. Cancer 1989; 63:742–747.

    Article  PubMed  CAS  Google Scholar 

  66. Fortner JG, Silva JS, Cox EBet al. Multivariate analysis of a personal series of247 patients with liver metastases from col orectal cancer. II. Treatment by intrahepatic chemotherapy. Ann Surg 1984;199:317–323.

    Article  PubMed  CAS  Google Scholar 

  67. GrafW, G!imelius B, Pahlman Let al. Determinants ofprognosis in advanced colorectal cancer. Bur JCancer1991; 27:1119–1123.

    Google Scholar 

  68. Lavin P, Mittleman A, Douglass Het al. Survival and response to chemotherapy for advanced colorectal adenocarcinoma: An Eastern Cooperative Oncology Group Report. Cancer 1980; 46:1536–1543.

    Article  PubMed  CAS  Google Scholar 

  69. Cady B, Stone MD, McDermott WV Jr. et al. Technical and biologic factors in disease-free survival after hepatic resection for colon cancer metastases. Arch Surg 1992; 127:561–569.

    PubMed  CAS  Google Scholar 

  70. Tsushima K, Nagorney OM, Rainwater LMet al. Prognostic significance of nuclear deoxyribonucleic acid ploidy patterns in resected hepatic metastases from colorectal carcinoma. Surgery 1987; 102:635–643.

    PubMed  CAS  Google Scholar 

  71. Kastrinakis WV, Ramchurren N, Rieger KMet al. Increased incidence ofp53 mutations is associated with hepatic metastasis in colorectal neoplastic progression. Oncogene 1995; 100:647–652.

    Google Scholar 

  72. Gennari L, Doci R, Bozzetti Pet al. Proposal for staging liver metastases. Recent Results Cancer Res 1986; 100:80–84.

    PubMed  CAS  Google Scholar 

  73. van de Velde CJH. The staging of hepatic metastases arising from colorectal cancer. Recent Results Cancer Res 1986; 100:85–90.

    PubMed  Google Scholar 

  74. Kavolius J, Pong Y, Blumgart LH. Surgical resection of metastatic liver tumors. Surg Oncol Clinics 1996; 5:337–352.

    CAS  Google Scholar 

  75. Jaques DP, Coit 0, Casper Eet al. Hepatic metastases from soft tissue sarcoma. Ann Surg 1995; 221:392–397.

    Article  PubMed  CAS  Google Scholar 

  76. Ihse I, Person B, Tibblin S. Neuroendocrine metastases of the liver. World JSurg 1995; 19:76–82.

    CAS  Google Scholar 

  77. Moertel CG. An odyssey in the land of small tumors. JClin Onco1 1987; 5:1503–1522.

    Google Scholar 

  78. Thompson GB, van Heerden JA, Grant CS. Islet cell carcinomas of the pancreas: a twenty year experience. Surgery 1988; 104:1011–1017.

    PubMed  CAS  Google Scholar 

  79. Que PG, Nagorney OM, Batts KPet al. Hepatic resection for metastatic neuroendocrine carcinoma. Am JSurg 1995; 169:36–43.

    Article  PubMed  CAS  Google Scholar 

  80. Norstein J, Silen W. Natural history ofliver metastases from colorectal carcinoma. Gastrointest Surg 1997; 1:398–407.

    Article  CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1998 Springer-Verlag London Limited

About this chapter

Cite this chapter

Lieser, M.J., Nagorney, D.M. (1998). The Natural History of Metastases to the Liver. In: Garden, O.J., Geraghty, J.G., Nagorney, D.M., Audisio, R.A., Stoldt, H.S. (eds) Liver Metastases. Springer, London. https://doi.org/10.1007/978-1-4471-1506-9_2

Download citation

  • DOI: https://doi.org/10.1007/978-1-4471-1506-9_2

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-4471-1508-3

  • Online ISBN: 978-1-4471-1506-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics